Skip to main content
Contact us

ATMP CDMO Companies
Advanced Therapies Contract Manufacturing Services

Your Trusted Partners for Advanced Therapies Contract Manufacturing and Development

Showing 13 facilities
JAFRAL
Slovenia

JAFRAL

JAFRAL

Integrated biotechnology facility providing R&D, non-GMP and GMP manufacturing, QC testing, and fill & finish services for advanced biologics.

SERVICES: Development services, Logistics, Analytical / QC services, Packaging, Regulatory services, Quality Assurance services, Manufacturing services

COMPLIANCE: ICH, FDA (cGMP), ISO, EMA (EU GMP), World Health Organization (GMP / HACCP), SQF (Safe Quality Food)

MARKETS: EMA (EU), PMDA (Japan), FDA (USA), Health Canada (Canada), ANVISA (Brazil), MHRA (UK), SFDA (Saudi Arabia), Turkish Health Authorities, EDE (UAE), CDSCO (India), TGA (Australia)

BSL (Biological Safety Level): 1, 2

CATEGORY / PRODUCT: COSMETICS, NUTRACEUTICALS, FDF / DRUG PRODUCTS, SERVICES, BIOLOGICS

USE: Human, Veterinary

BATCH SIZE: Large, Small, Medium

CONTROLLED SUBSTANCES: Lowest potential for abuse

THERAPEUTIC AREAS OF EXPERTISE (ATC): (J) Antiinfectives for systemic use, (D) Dermatologicals, (V06) Nutrients, (R) Respiratory system, (A) Digestive tract and metabolism

REGION: Europe

VIVEbiotech
Spain

VIVEbiotech

VIVEbiotech

Your leading GMP-certified CDMO exclusively dedicated to the production of lentiviral vectors.

MARKETS: EMA (EU), FDA (USA), MHRA (UK)

REGION: Europe

COMPLIANCE: FDA (cGMP), French Service-Public (CIR), EMA (EU GMP), MHRA (UK GMP)

BATCH SIZE: Large, Small, Medium

USE: Human

BSL (Biological Safety Level): 1, 2

SERVICES: Development services, Manufacturing services, Analytical / QC services, Quality Assurance services, Regulatory services, Packaging

CATEGORY / PRODUCT: BIOLOGICS

HISTOCELL S.L. | Cell Therapy, Exosomes & Secretomes
Spain

HISTOCELL S.L. | Cell Therapy, Exosomes & Secretomes

HISTOCELL

Histocell is a Spanish CDMO that develops and manufactures cell therapies, secretomes and exosomes, as well medical devices.

THERAPEUTIC AREAS OF EXPERTISE (ATC): (C) Cardiovascular system, (D) Dermatologicals, (M) Musculoskeletal system, (N) Nervous system, (R) Respiratory system, (B) Blood and blood forming organs, (A) Digestive tract and metabolism

MARKETS: MHRA (UK), ANMAT (Argentina), INVIMA (Colombia), MFDS (South Korea), CDSCO (India), TGA (Australia), EMA (EU), PMDA (Japan), NMPA (China), FDA (USA), Health Canada (Canada), ANVISA (Brazil), ISP (Chile), MSPAS (Guatemala), COFEPRIS (Mexico), DIGEMID (Peru), Russian Health Authorities

BATCH SIZE: Small, Medium

COMPLIANCE: EMA (EU GMP), ISO

CATEGORY / PRODUCT: BIOLOGICS, SERVICES, FDF / DRUG PRODUCTS, COSMETICS

REGION: Europe

USE: Human, Veterinary

BSL (Biological Safety Level): 1, 2

SERVICES: Development services, Manufacturing services, Analytical / QC services, Quality Assurance services

MARKETS: EMA (EU), ANVISA (Brazil), CDSCO (India)

SERVICES: Logistics, Development services, Manufacturing services, Analytical / QC services, Quality Assurance services, Regulatory services, Packaging

REGION: Europe

COMPLIANCE: ISO, ANVISA (Brazil B-GMP), EMA (EU GMP), World Health Organization (GMP / HACCP)

USE: Human

BSL (Biological Safety Level): 1, 2

THERAPEUTIC AREAS OF EXPERTISE (ATC): (R) Respiratory system, (A) Digestive tract and metabolism, (G) Genito urinary system and sex hormones

BATCH SIZE: Small

CATEGORY / PRODUCT: BIOLOGICS, FDF / DRUG PRODUCTS

Cellex Cell Professionals
Germany

Cellex Cell Professionals

Cellex Cell Professionals

CGT CDMO Cell Manufacturing Plant and Collection Center for Starting Materials

MARKETS: EMA (EU), FDA (USA)

SERVICES: Logistics, Development services, Manufacturing services, Analytical / QC services, Quality Assurance services, Regulatory services, Packaging

REGION: Europe

COMPLIANCE: FDA (cGMP), EMA (EU GMP)

BATCH SIZE: Large, Small, Medium

USE: Human, Veterinary

BSL (Biological Safety Level): 1, 2

CATEGORY / PRODUCT: BIOLOGICS, SERVICES, FDF / DRUG PRODUCTS

Green Phoenix Labs GmbH
Germany

Green Phoenix Labs GmbH

Green Phoenix Labs GmbH

Cell Therapy company with excess Cleanroom capacity.

THERAPEUTIC AREAS OF EXPERTISE (ATC): (R) Respiratory system, (B) Blood and blood forming organs, (A) Digestive tract and metabolism, (G) Genito urinary system and sex hormones, (C) Cardiovascular system, (D) Dermatologicals, (M) Musculoskeletal system, (N) Nervous system

CONTROLLED SUBSTANCES: Lowest potential for abuse, Low potential for abuse, Lower potential for abuse

BATCH SIZE: Small, Medium

OEB (Occupational Exposure Banding): 2 (PDE = 1,000 - 10,000 µg/day), 3 (PDE = 100 - 1,000 µg/day), 1 / low-hazard (PDE > 10,000 µg/day)

COMPLIANCE: EMA (EU GMP)

CATEGORY / PRODUCT: BIOLOGICS, SERVICES, FDF / DRUG PRODUCTS

MARKETS: EMA (EU)

SERVICES: Logistics, Development services, Manufacturing services, Quality Assurance services, Regulatory services, Packaging

REGION: Europe

USE: Human

BSL (Biological Safety Level): 1

Limited view

COSMETICS manufacturing site

MAI network supplier

Creative Biostructure was founded with a strong focus on structural biology and membrane protein research.

Location available after registration

Limited view

COSMETICS manufacturing site

MAI network supplier

One-stop CDMO Solutions for APl and Key intermediates.

Location available after registration

Limited view

BIOLOGICS manufacturing site

MAI network supplier

Your trusted CDMO partner with experience in the development and manufacturing of biopharmaceuticals, viral vectors, and vaccines.

Location available after registration

More facilities on the network

Register to unlock the full catalog with contact details and locations.

+4 more facilities

Create free account

As cell, gene, and tissue therapies continue to redefine the boundaries of medicine, specialized ATMP CDMO companies have become essential partners in bringing these complex treatments to life. Advanced Therapy Medicinal Products (ATMPs), including CAR-T cells, stem cell-based therapies, and genetically modified treatments, require cutting-edge manufacturing, strict compliance, and customized development approaches.

Whether you are a biotech startup developing a pioneering gene therapy or a pharmaceutical company scaling up a tissue-engineered product, partnering with a reliable contract manufacturer for advanced therapies ensures your innovation moves smoothly from concept to clinic.

How to Choose an ATMP CDMO Company

Not all CDMOs are equipped to handle advanced therapies. Here are the key criteria to consider when selecting an ATMP CDMO:

  • Regulatory readiness: Proven experience with GMP requirements for ATMPs, including EMA and FDA-specific guidelines
  • Specialized facilities: Cleanrooms for aseptic processing, viral vector suites, and segregated environments for autologous vs. allogeneic therapies
  • Scalability: Capability to support the transition from preclinical batches to commercial production
  • Quality control and analytics: Advanced characterization tools to assess potency, purity, and safety of cell and gene therapies
  • Technology transfer expertise: Seamless integration of academic, R&D, or early-stage platforms into GMP operations

Choosing the right partner from the start helps avoid costly delays and long-term compliance risks.

Key Services Offered by Advanced Therapy Contract Manufacturers

Leading services in contract manufacturing for advanced therapies include:

  • Process development for viral vectors, stem cells, and genetically modified cells
  • GMP manufacturing from Phase I through commercial scale
  • Viral vector production (lentivirus, AAV, adenovirus, retrovirus)
  • Cell therapy services, including expansion, transduction, and cryopreservation
  • Fill and finish services under aseptic conditions
  • Analytical method development and validation for potency and identity testing
  • Cold chain logistics and controlled distribution

These services are essential for ATMPs, where the product is often living, highly sensitive, and patient-specific.

Benefits of Partnering with ATMP CDMO Companies

Working with experienced ATMP CDMOs offers major advantages:

  • Risk reduction: Experienced CDMOs anticipate complex scientific and regulatory challenges
  • Faster timelines: Integrated development and GMP readiness accelerate IND/IMPD submissions
  • Purpose-built infrastructure: Facilities and processes designed specifically for complex therapies
  • Compliance assurance: These CDMOs have successfully passed rigorous ATMP-specific inspections
  • Focus on innovation: Your internal teams can focus on R&D while the CDMO manages scale-up and production

The right ATMP CDMO doesn’t just manufacture your therapy — it becomes an integral part of your development strategy.

ATMP CDMO Companies

Among the leading ATMP CDMO companies worldwide are:

  • VIVEbiotech: GMP-certified CDMO and leading company exclusively dedicated to lentiviral vector production. [View CDMO Profile]
  • Histocell: ATMP CDMO that develops and manufactures cell therapies from iPSC, MSC, secretomes, exosomes, and other cell types, as well as medical devices and dermocosmetic products. [View CDMO Profile]
  • Cellex Cell Professionals: CGT CDMO with a cell manufacturing plant and a collection center for starting materials. [View CDMO Profile]
  • Green Phoenix Labs GmbH: Cell therapy company offering excess cleanroom capacity to support advanced pharmaceutical and biotechnological manufacturing activities. [View CDMO Profile]
  • Demo facility: Tissue therapy, Cell therapy and GTMP (Gene Therapy). [View CDMO Profile]

These companies have the resources required to meet the strict standards of ATMP development while supporting rapid growth and innovation.

Related Information

Let MAI CDMO Network Help You Find the Right ATMP CDMO Partner

At MAI CDMO Network, we help you navigate the complex world of ATMP CDMO companies. Whether you need viral vector development, clinical manufacturing of cell therapies, or support for the industrialization of a commercial gene therapy, we connect you with the most qualified experts in advanced therapy contract manufacturing worldwide.

Ready to accelerate your ATMP development? Contact us today to find a CDMO suited to your therapy, timeline, and regulatory strategy.